Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas

Similar documents
Nicolas Bianchi M.D. May 15th, 2012

Alan Barber. Professor of Clinical Neurology University of Auckland

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

CEREBRO VASCULAR ACCIDENTS

Vascular Disorders. Nervous System Disorders (Part B-1) Module 8 -Chapter 14. Cerebrovascular disease S/S 1/9/2013

Cryptogenic Strokes: Evaluation and Management

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

The randomized study of efficiency and safety of antithrombotic therapy in

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

ICD-9 to ICD-10 Crosswalk Adult Codes

Documentation for the IRF Provider

InterQual Level of Care 2018 Index

CMS Limitations Guide - Radiology Services

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

2017 Stroke Statistics

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Dental Management Considerations for Patients on Antithrombotic Therapy

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE OR TIA December 8, 2017

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Search strategy for RCTs of PPV on Medline, Embase and CENTRAL

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Speakers. 2015, American Heart Association 1

MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS


JAWDA Guidelines for Pre-hospital Emergency Medical Service (EMS)

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

: STROKE. other pertinent information such as recent trauma, illicit drug use, pertinent medical history or use of oral contraceptives.

Cardiovascular Diseases and Diabetes

Is Stroke Frequency Declining?

Supplementary Online Content

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Long-Term Care Updates

DISORDERS OF THE NERVOUS SYSTEM

Cerebrovascular accident icd 10

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE

Management and Investigation of Ischemic Stroke By Etiology

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

PFO closure group total no. PFO closure group no. of males

Vague Neurological Conditions

ANTI-THROMBOTIC THERAPY in NON-VALVULAR ATRIAL FIBRILLATION

Disclosure Statement: Dr. Knoefel has nothing to disclose

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

PFO Management update

Non-commercial use only

An Introduc+on to Stroke

Cerebrovascular Disease

DOAC: future possibili indicazioni

Secondary Stroke Prevention: A Precautionary Tale

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

Guideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)

Cognitive Rehabilitation

Bridging anticoagulation definition

LOW DOSE ASPIRIN CARDIOVASCULAR DISEASE FOR PROPHYLAXIS OF FOR BACKGROUND USE ONLY NOT TO BE USED IN DETAILING

Cryptogenic Stroke: A logical approach to a common clinical problem

Modena, 6 novembre Heart and Brain. Paolo Bovi

Extracranial Carotid Artery Stenting With or Without Distal Protection Device

Yes No Unknown. Major Infection Information

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

Asif Serajian DO FACC FSCAI

Appendix Criteria used for the automated chart review

Supplementary Online Content

TIA as Acute Cerebrovascular Syndrome

Update overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab

TABLE OF CONTENTS. MODULE 1: Pathophysiology of Stroke, Neuroanatomy, and Stroke Syndromes. MODULE 2: Acute Stroke Management

CRITICALLY APPRAISED PAPER (CAP)

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

LABETTE COMMUNITY COLLEGE BRIEF SYLLABUS. Please check with the LCC bookstore for the required texts for this class.

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Cancer and Heart/Stroke

Surgical Treatment of Carotid Disease

Stroke Net Grand Round Webinar

Visual Field Defects and the Prognosis of Stroke Patients

ICD-10-CM - Session 2. Cardiovascular Conditions, Neoplasms and Diabetes

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

Cerebrovascular Disease

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

INSTITUTE OF NEUROSURGERY & DEPARTMENT OF PICU

GERIATRICS CASE PRESENTATION

Supplementary webappendix

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

PTA 106 Unit 1 Lecture 3

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Cardiovascular Disease

Practical Considerations in the Early Treatment of Acute Stroke

Retrospective Study on the Safety and Efficacy of Clopidogrel in the Treatment of Acute Cerebral Infarction

2016 Stroke Statistics

Transcription:

Current Clinical Trials for Survivors in NJ and Philadelphia Areas For more information go to https://clinicaltrials.gov/ and search for the title in search box Condition / Disease 1. Spatial Neglect and Bias in Near and Far Space 2. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic 3. Mild and Rapidly Improving Study Ischemic 4. Dabigatran Etexilate for Secondary Prevention in Patients With Embolic of Undetermined Source (RE-SPECT ESUS) ; Secondary Prevention 5. Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With 6. POSITIVE Clinical Trial Ischemic 7. HT-3951 vs. Placebo in Rehabilitation Ischemic

8. Rivaroxaban Versus Aspirin in Secondary Prevention of and Prevention of Systemic Embolism in Patients With Recent Embolic of Undetermined Source (ESUS) 9. Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Chronic Ischemic 10. Platelet-Oriented Inhibition in New TIA and Minor Ischemic (POINT) Trial Ischemic Attack, Transient 11. Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Acute Ischemic ; Thrombotic Disease 12. Hyperglycemia Insulin Network Effort (SHINE) Trial Acute Ischemic ; Diabetes; Hyperglycemia 13. Endovascular Therapy Following Imaging Evaluation for Ischemic 3, Acute; Cerebral Infarction 14. A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure Heart Failure; Coronary Artery Disease

15. Study of Procoagulation Markers in Patients ; Hyperglycemia; Procoagulation Markers 16. Apixaban for the Reduction of Thrombo-Embolism in Patients With Device- Detected Sub-Clinical Atrial Fibrillation Atrial Fibrillation; 17. Ischemia Care Biomarkers of Acute Etiology (BASE) Ischemic ; Atrial Fibrillation; Transient Ischemic Attacks; Transient Cerebrovascular Events; Thrombotic ; of Basilar Artery; Cardioembolic 18. Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA Cerebrovascular Accident (CVA); ; Hemiplegia 19. AMPLATZER Amulet LAA Occluder Trial 20. Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes Carotid Artery Stenosis; s 21. Testing the Developmental Origins Hypothesis Diabetes; ; Obesity 22. A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Heart Failure; Respiratory Insufficiency; Acute; Infectious Diseases; Rheumatic Diseases

23. BOTOX Open-Label Treatment in Pediatric Upper Limb Spasticity Pediatrics; Muscle Spasticity; Cerebral Palsy; 24. BOTOX Treatment in Pediatric Upper Limb Spasticity Pediatrics; Muscle Spasticity; Cerebral Palsy; 25. A Model to Identify Specific Predictors of Spatial Neglect Recovery Spatial Neglect; Hemispatial Neglect; Hemineglect; Unilateral Neglect; Visual Spatial Neglect; Sensory Neglect 26. Cardiovascular Inflammation Reduction Trial Cardiovascular Disease 27. Optical Measurement of Cerebral Hemodynamics in Children With Acute Arterial Ischemic Acute Arterial Ischemic 28. Asymmetrical Gait Training After Pediatric ; Hemiplegia 29. Dosage and Predictors of Naming Treatment Response in Aphasia Aphasia; 30. Quality of Life After Using a Telemedicine-based Network 31. Usability Testing of Affordable Haptic Robots for Therapy ; Hemiplegia 32. Usability Testing of a Bilateral Activities of Daily Exercise Robot for Therapy ; Cerebral Palsy 33. Improving Coordination and Transitions of Care in Patients ; Transient Ischemic Attack

34. Design of an Affordable Gym for Post Rehabilitation ; Cerebral Palsy; Healthy 35. Robot-Assisted Rehabilitation Based on Patient-Therapist Interactions ; Hemiplegia; Healthy 36. Connected Health Blood Pressure Monitoring In and TIA Patients ; Ischemic Attack, Transient 37. Diffuse Optical Monitoring With Inhaled Nitric Oxide 38. Non-invasive Measurement of Cerebral Dynamic Autoregulation 39. TMS as a Biological Marker of Neuroplasticity ; Aphasia 40. Arm Motor Control on Bi and Uni ADLs ; Peripheral Neuropathy; Spinal Cord Injuries; Cerebral Palsy 41. SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants Cerebral Palsy; Developmental Delay; ; Fine Motor Delay; Infant Development; Other Development Delays 42. Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor Traumatic Brain Injury; Ischemic ; Intracerebral Hemorrhage; Subarachnoid Hemorrhage; Acute Anoxic Encephalopathy